ASHLEY OLDHAM: Open Payments
NPI 1669858429 · BLUE SPRINGS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$387 in 21 payments from 14 companies in 2025. Trend: 2023 $142 · 2024 $17 · 2025 $387
Food & beverage: $387
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $68 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $42 |
| ABBVIE INC. | 2 | $41 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Novo Nordisk Inc | 2 | $33 |
| Astellas Pharma US Inc | 1 | $26 |
| Antares Pharma, Inc. | 1 | $22 |
| Alexion Pharmaceuticals, Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: JOURNAVX, REXULTI, NURTEC ODT, Veozah, UBRELVY, XYOSTED, STRENSIQ, Ozempic.
Industry payments across MO — which companies pay providers there.
